Catalent on Thursday announced the opening of a new facility in San Diego, in response to increased demand from pharmaceutical and biopharmaceutical customers for integrated development, clinical packaging and distribution solutions on the West Coast.
The new 24,000-square-foot facility, located within a mile of the company’s early-phase oral drug product Center of Excellence, marks the latest expansion to Catalent’s global clinical supply network, and follows the opening of a new site in Japan earlier this month.
The San Diego location will support clinical studies in phases 1-3. The site offers end-to-end services, including supply management, primary and secondary packaging and labeling, storage, distribution, returns and destruction.
“Our new full-service San Diego supply facility is strategically located to work in tandem with our development center and serve customers not only on the West Coast of the U.S. and Canada, but across the world,” said Kristen DeVito, vice president of operations, clinical supply services, North America, at Catalent. “In addition to investments we have made across our global network, the site is part of a wider strategy to provide local, integrated supply services, which offer a supply chain advantage as the world adjusts to the impact of the pandemic and its inherent logistical challenges.”
